Evidence map›Paper›PMID 20038947›Full record

ArticleMolecular psychiatry2011

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

S I Shyn, J Shi, J B Kraft, J B Potash, J A Knowles, M M Weissman, H A Garriock, J S Yokoyama, P J McGrath, E J Peters and 10 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 16 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 16 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive disorder: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2014
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 2 countries.

S I ShynDepartment of Psychiatry and Institute for Human Genetics, University of California, San Francisco, CA, USA.
J Shi
J B Kraft
J B Potash
J A Knowles
M M Weissman
H A Garriock
J S Yokoyama
P J McGrath
E J Peters
W A Scheftner
W Coryell
W B Lawson
D Jancic
P V Gejman
A R Sanders
P Holmans
S L Slager
D F Levinson
S P Hamilton
University of California, San Francisco · USJohns Hopkins University · USNorthShore University HealthSystem · USStanford University · USCardiff University · GBColumbia University · USHoward University · USMayo Clinic · USNew York State Psychiatric InstituteRush University · USUniversity of Iowa · USUniversity of Southern California · US

Funding

AN NCRR CENTER FOR HIGH THROUGHPUT SNP GENOTYPING AND ANALYSIS: GAIN NETWORKU54RR020278 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2004 to 2008
$14.4M
PREDOCTORAL TRAINING CONSORTIUM IN AFFECTIVE SCIENCET32MH020006 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI GROSS, JAMES J, JOHNSON, SHERI L · 1998 to 2018
$5.9M
PROGRAM FOR MINORITY RESEARCH TRAINING IN PSYCHIATRY (PMT32MH019126 · NIMH · AMERICAN PSYCHIATRIC INST FOR RES &EDUC · PI REGIER, DARREL A · 1989 to 2009
$5.3M
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERSR25MH060482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL H MATHALON, Susan M. Voglmaier · 2000 to 2026
$5.2M
Pharmacogenomics of Antidepressant ResponseR01MH072802 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAMILTON, STEVEN P. · 2005 to 2008
$4.6M
MOLECULAR APPROACHES TO MENTAL ILLNESST32MH019552 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARONDES, SAMUEL H. · 1992 to 2006
$1.4M
Role of OPRM1 in an Antidepressant Response and Major Depressive DisorderF32MH082562 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARRIOCK, HOLLY A · 2008 to 2008
$51k
TREATMENT RESISTANT DEPRESSION-278990003N01MH090003 · NIMH · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1999 to 2003
–
Medical Research Council G0800509NCRR NIH HHS U54 RR020278NIMH NIH HHS F32 MH082562NIMH NIH HHS MH072802NIMH NIH HHS N01 MH090003NIMH NIH HHS R01 MH072802NIMH NIH HHS R25 MH060482NIMH NIH HHS T32 MH019126NIMH NIH HHS T32 MH019552NIMH NIH HHS T32 MH020006NIMH NIH HHS T32 MH19126NIMH NIH HHS T32 MH19552
6 · The paper itself

Abstract

We report a genome-wide association study (GWAS) of major depressive disorder (MDD) in 1221 cases from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 1636 screened controls. No genome-wide evidence for association was detected. We also carried out a meta-analysis of three European-ancestry MDD GWAS data sets: STAR*D, Genetics of Recurrent Early-onset Depression and the publicly available Genetic Association Information Network-MDD data set. These data sets, totaling 3957 cases and 3428 controls, were genotyped using four different platforms (Affymetrix 6.0, 5.0 and 500 K, and Perlegen). For each of 2.4 million HapMap II single-nucleotide polymorphisms (SNPs), using genotyped data where available and imputed data otherwise, single-SNP association tests were carried out in each sample with correction for ancestry-informative principal components. The strongest evidence for association in the meta-analysis was observed for intronic SNPs in ATP6V1B2 (P=6.78 x 10⁻⁷), SP4 (P=7.68 x 10⁻⁷) and GRM7 (P=1.11 x 10⁻⁶). Additional exploratory analyses were carried out for a narrower phenotype (recurrent MDD with onset before age 31, N=2191 cases), and separately for males and females. Several of the best findings were supported primarily by evidence from narrow cases or from either males or females. On the basis of previous biological evidence, we consider GRM7 a strong MDD candidate gene. Larger samples will be required to determine whether any common SNPs are significantly associated with MDD.

Indexed as

Genome-Wide Association StudyAdolescentAdultAgedAge of OnsetEuropeFemaleGene Expression ProfilingGenotypeHumansMajor Depressive DisorderMaleMeta-Analysis as TopicMiddle AgedOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideReceptors, Metabotropic GlutamateSP4 protein, humanSp4 Transcription FactorVacuolar Proton-Translocating ATPases

Identifiers

PMID20038947
PMCPMC2888856
OpenAlexW2149375666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.